Glioblastoma Archive | IOZK

CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model

2020-06-24/in Dendritic Cells, Glioblastoma, International Publications /von 2020-06-24 / Mol Ther Oncolytics 2020 Sep;18:295-303

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion

2020-06-05/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2020-06-05 / Cells 2020 Jun;9(6)

Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1

2020-05-13/in Dendritic Cells, Glioblastoma, International Publications /von 2020-05-13 / Hum Vaccin Immunother 2020 May;:1-9

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors

2020-01-16/in Dendritic Cells, Glioblastoma, International Publications /von 2020-01-16 / NPJ Vaccines 2020;5:5

The current state of immunotherapy for gliomas: an eye toward the future

2019-09-01/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666

Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells

2019-08-09/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2019-08-09 / J Extracell Vesicles 2019;8(1):1648995

Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

2019-06-17/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)

A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials

2019-04-15/in Dendritic Cells, Glioblastoma, International Publications /von 2019-04-15 / Cancers (Basel) 2019 Apr;11(4)

Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy

2019-04-01/in Dendritic Cells, Glioblastoma, International Publications /von 2019-04-01 / Anticancer Res. 2019 Apr;39(4):2043-2051

An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma

2019-01-07/in Dendritic Cells, Glioblastoma, International Publications /von 2019-01-07 / Int. J. Cancer 2019 Jun;144(11):2867-2879